Gene expression analyses, in turn, revealed in agreement with the observed DUSP6 rise in the majority of resistant tumours, that re‐activation of the RAS pathway is critical for developing primary and SR (Fig. 6C,D). Here, DUSP6 is linked to neoplasm.